Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial

- Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance after stabilization and before discharge compared with placebo - The benefit was consistent in adults with new or existing heart failure and in those with